Last edition
News about "Innocan Pharma "
After India, Innocan Pharma Secures Patent Allowance in Japan for Liposomal CBD Delivery Platform
Israel-based pharmaceutical technology company Innocan Pharma Corporation has announced that its patent for the liposomal delivery platform LPT-CBD has been allowed in Japan and will be officially granted following the completion of administrative process.
Innocan Pharma | 16/10/2025 | By Dineshwori | 190
Innocan Pharma Secures its First Patent in India for its Liposomal CBD Injection
This granted patent protects Innocan's synthetic Cannabidiol-loaded Liposome Injection Platform (LPT-CBD), designed for precise dosing and sustained release of Synthetic CBD into the bloodstream.
Innocan Pharma | 19/02/2025 | By Aishwarya | 395
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy